cytarabine has been researched along with Keratoconjunctivitis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ioannidis, AS; Samarawickrama, C; Watson, SL; Wechsler, AW | 1 |
Jenkins, A; Kell, J; Lane, C; Patel, AK; Sheehan, W | 1 |
Aisa, Y; Ichimura, M; Kato, J; Kawata, Y; Mori, T; Ogawa, Y; Okamoto, S; Shigematsu, N; Shimizu, T; Tsubota, K; Tsuneyama, C; Yamane, A; Yashima, T | 1 |
Aisa, Y; Ikeda, Y; Ito, C; Kato, J; Kobayashi, N; Kondo, S; Kubo, A; Kurotori-Sotome, T; Mori, T; Ogawa, Y; Okamoto, S; Shigematsu, N; Tsubota, K; Watanabe, M; Yamada, K; Yashima, T | 1 |
Gococo, KO; Lass, JH; Lazarus, HM | 1 |
Barletta, JP; Fanous, MM; Margo, CE | 1 |
2 trial(s) available for cytarabine and Keratoconjunctivitis
Article | Year |
---|---|
Prophylactic treatment for cytosine arabinoside-induced keratoconjunctivitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Leukemia, Myeloid, Acute; Male; Middle Aged; Ophthalmic Solutions; Prednisolone; Treatment Outcome; Young Adult | 2011 |
The use of prophylactic eye drops during high-dose cytosine arabinoside therapy.
Topics: Administration, Topical; Cytarabine; Deoxycytidine; Double-Blind Method; Humans; Keratoconjunctivitis; Ophthalmic Solutions; Prednisolone; Prospective Studies | 1992 |
4 other study(ies) available for cytarabine and Keratoconjunctivitis
Article | Year |
---|---|
Bilateral corneal infections associated with topical steroid therapy prophylaxis for cytarabine arabinoside-induced keratoconjunctivitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Cytarabine; Female; Humans; Keratoconjunctivitis; Middle Aged | 2014 |
Prevention of cytarabine-induced kerato-conjunctivitis by eye rinse in patients receiving high-dose cytarabine and total body irradiation as a conditioning for hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Keratoconjunctivitis; Male; Middle Aged; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult | 2011 |
Reduced efficacy of topical corticosteroid in preventing cytarabine-induced kerato-conjunctivitis in patients receiving high-dose cytarabine and total body irradiation for allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Keratoconjunctivitis; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2008 |
Corneal and conjunctival toxicity with low-dose cytosine arabinoside.
Topics: Conjunctiva; Cornea; Cytarabine; Dexamethasone; Humans; Keratoconjunctivitis; Leukemia, Myeloid, Acute; Male; Middle Aged; Visual Acuity | 1992 |